# FDA Inspection 1091668 - Janssen Pharmaceuticals, dba Actelion Pharmaceutical - February 28, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceuticals-dba-actelion-pharmaceutical/cad3bf3a-2b4e-47e6-a75f-4178a313cf80
Source feed: FDA_Inspections

> FDA Inspection 1091668 for Janssen Pharmaceuticals, dba Actelion Pharmaceutical on February 28, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1091668
- Company Name: Janssen Pharmaceuticals, dba Actelion Pharmaceutical
- Inspection Date: 2019-02-28
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 988929 - 2016-09-21](https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceuticals-dba-actelion-pharmaceutical/a1a51288-f60d-4821-866f-1336cd61c325)
- [FDA Inspection 873005 - 2014-02-12](https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceuticals-dba-actelion-pharmaceutical/9f647e8d-2e4c-4138-82ba-785dd4ad41db)
- [FDA Inspection 873005 - 2014-02-12](https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceuticals-dba-actelion-pharmaceutical/b132a489-5352-42c8-b852-0b7ab1f244fd)
- [FDA Inspection 735438 - 2011-07-21](https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceuticals-dba-actelion-pharmaceutical/5ce130c7-ded5-48ca-bb07-293fd0b92f28)
- [FDA Inspection 599116 - 2009-07-20](https://www.globalkeysolutions.net/records/fda_inspections/janssen-pharmaceuticals-dba-actelion-pharmaceutical/9e7f7edd-3f62-4ce4-8177-85960a87eec3)

Company: https://www.globalkeysolutions.net/companies/janssen-pharmaceuticals-dba-actelion-pharmaceutical/8d00c775-7a8c-41d5-aa2d-f2154459469d

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c